Calprotectin by Geneva Diagnostics is a valuable clinical marker for inflammation associated with infectious, ulcerative and malignant processes of the GI tract. It is the noninvasive "test of choice" for differentiating Irritable Bowel Syndrome (IBS) from Inflammatory Bowel Disease (IBD). The United States Food and Drug Administration (FDA) has approved this test as a means to aid physicians in diagnosing Crohn's Disease and ulcerative colitis.
Dr. David Scheiderer MD, MBA, DFAPA, is the Chief Medical Officer and Director of Education at Integrative Psychiatry, Inc. in Sarasota, Florida and the President of Tiberius Enterprises, Inc. in Roanoke, Virginia. An accomplished clinician, educator, and lecturer, Dr. Dave has established himself as a key opinion leader in the fields of both mainstream psychiatry and functional medicine. Dissatisfied with the patient outcomes using only conventional treatments, he began treating his patients by addressing biological imbalances with lifestyle improvements, nutrition and nutraceuticals to get better outcomes. His integrative approach provided much improved results. Dr. Dave is passionate about helping the community he serves by personalizing treatments and educating the public about mental health and healthy aging. He has formulated several of our supplements and sat on the advisory board for many others, ensuring the products we carry are based on science and experience and have the best efficacy rates and highest ingredient quality available.